Increased Telomerase Improves Motor Function and Alpha-Synuclein Pathology in a Transgenic Mouse Model of Parkinson’s Disease Associated with Enhanced Autophagy
Protective effects of the telomerase protein TERT have been shown in neurons
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Protective effects of the telomerase protein TERT have been shown in neurons
Alpha-synuclein is a major component of intra-neuronal inclusions found in Lewy bodies in Parkinson?s disease patients. The mitochondria represent a highly promising target for the development ... oxidative energy…
Alpha-synuclein is a major component of intra-neuronal inclusions found in Lewy bodies in Parkinson?s disease patients. The mitochondria represent a highly promising target for the development ... oxidative energy…
Backgrounds: Accumulation and aggregation of alpha-synuclein in dopaminergic neurons is one of pathogenesis of Parkinson’s disease (PD), and its formation is partly regulated by long-chain polyunsaturated fatty ... mice…
Backgrounds: Accumulation and aggregation of alpha-synuclein in dopaminergic neurons is one of pathogenesis of ParkinsonÃ?¢Ã?Â?Ã?Â?s disease (PD), and its formation is partly regulated ... mice were resistant to…
there is still much to be elucidated regarding the role of CYP46A1 in PD. Alpha-Synuclein, the symbol of pathological protein of PD, exhibits a pronounced affinity for binding
Alpha-synuclein aggregation is a critical pathological process implicated in neurodegenerative diseases such as Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). This review…
Alpha-synuclein (α-syn) protein is the major component of Lewy bodies, which are characteristic pathological trademarks for neurodegenerative diseases (e.g. Parkinson’s and Alzheimer’s diseases). It is primarily
development of such neurodegenerative diseases as Alzheimer?s and Parkinson?s disease (PD). Alpha-synuclein (α-Syn), misfolding and nanoassembly of which tightly linked to the development
Objective: We previously reported that the ability of vascular remodelling is impaired
Alpha-synuclein is a major component of intra-neuronal inclusions found in Lewy bodies in Parkinson?s disease patients. The mitochondria represent a highly promising target for the development ... oxidative energy…
dominant and recessive form of Parkinson’s disease caused by the abnormal aggregation of Alpha-synuclein and PTEN- induced putative kinase 1 protein. The present study focuses on developing lead
formation of intra-neuronal inclusions called Lewy bodies which are comprised of alpha-synuclein (α-syn). PD is primarily a movement disorder but patients are known to experience memory deficit
Background: The false folded protein of alpha (α) synuclein forms aggregation and
The formation of α-synuclein (aS) amyloid aggregates, called Lewy bodies (LBs
The formation of α-synuclein (aS) amyloid aggregates, called Lewy bodies (LBs
expression in a mouse model of Parkinson’s disease (PD) overexpressing human wild type alpha-synuclein. Our aim was to test whether increased Tert expression levels were able to ameliorate ... reactive oxygen species…
Increasing evidences suggest that phosphorylation at S129 (pS129) may be an important regulator of alpha-synuclein aggregation, Lewy bodies formation and neurotoxicity in ParkinsonâÂ?Â?s disease (PD) and related…
broad-based tyrosine kinase inhibitor. According to preclinical data, nilotinib lowers brain alpha-synuclein levels and lessens inflammation in Parkinson's Disease (PD) animals. As we previously demonstrated, nilotinib…
cerebellum type (MSA-C). The pathology of this disease is the accumulation of alpha-synuclein in oligodendrocyte. And because of this, it belongs to synucleinopathies. Alpha-synuclein is a kind
For authors and organisers
Find the right journal for your paper and submit your manuscript.